Cargando…

Exploring new pathways in the treatment of hepatocellular cancer

Detalles Bibliográficos
Autores principales:	Masior, Łukasz, Grąt, Michał
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475451/ https://www.ncbi.nlm.nih.gov/pubmed/32953780 http://dx.doi.org/10.21037/atm-20-3629

Ejemplares similares

Methods of Attenuating Ischemia-Reperfusion Injury in Liver Transplantation for Hepatocellular Carcinoma
por: Masior, Łukasz, et al.
Publicado: (2021)

The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer
por: Grąt, Michał, et al.
Publicado: (2016)

Surgical treatment of hepatic Echinococcus granulosus
por: Patkowski, Waldemar, et al.
Publicado: (2017)

Importance of Intraoperative Transfusions of Packed Red Blood Cells and Fresh Frozen Plasma in Liver Transplantation for Hepatocellular Cancer
por: Masior, Łukasz, et al.
Publicado: (2020)

Limitations of predicting microvascular invasion in patients with hepatocellular cancer prior to liver transplantation
por: Grąt, Michał, et al.
Publicado: (2017)

Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer
por: Grąt, Michał, et al.
Publicado: (2017)

Effects of Donor Age and Cold Ischemia on Liver Transplantation Outcomes According to the Severity of Recipient Status
por: Grąt, Michał, et al.
Publicado: (2015)

Results of liver transplantation in patients with acute liver failure due to Amanita phalloides and paracetamol (acetaminophen) intoxication
por: Krasnodębski, Maciej, et al.
Publicado: (2015)

Alpha-Fetoprotein Response after First Transarterial Chemoembolization (TACE) and Complete Pathologic Response in Patients with Hepatocellular Cancer
por: Masior, Łukasz, et al.
Publicado: (2023)

Post-hoc analysis of a randomized controlled trial on the impact of pre-transplant use of probiotics on outcomes after liver transplantation
por: Grąt, M., et al.
Publicado: (2020)

Impact of Body Composition on the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation
por: Grąt, Karolina, et al.
Publicado: (2019)

Extremes of Liver Transplantation for Hepatocellular Carcinoma
por: Grąt, Michał, et al.
Publicado: (2019)

Prognostic Relevance of a Complete Pathologic Response in Liver Transplantation for Hepatocellular Carcinoma
por: Grąt, Michał, et al.
Publicado: (2019)

Ischemia-reperfusion injury and the risk of hepatocellular carcinoma recurrence after deceased donor liver transplantation
por: Grąt, Michał, et al.
Publicado: (2018)

Combination of Morphologic Criteria and α-Fetoprotein in Selection of Patients With Hepatocellular Carcinoma for Liver Transplantation Minimizes the Problem of Posttransplant Tumor Recurrence
por: Grąt, Michał, et al.
Publicado: (2014)

Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver Disease
por: Grąt, Karolina, et al.
Publicado: (2020)

New potential instrument to fight hepatocellular cancer by restoring p53
por: Vincent, Franklin C., et al.
Publicado: (2011)

New era exploring the brain
por: Kim, Manho
Publicado: (2021)

Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
por: Song, Jaewhan
Publicado: (2020)

UBE2T: A new molecular regulator of cancer stemness in hepatocellular carcinoma
por: Leung, Rainbow Wing Hei, et al.
Publicado: (2021)

Exploring a New Era in Uveitis
por: Sengupta, Sabyasachi, et al.
Publicado: (2020)

Exploring new substance use settings
por: Hellman, Matilda
Publicado: (2017)

Biomarkers for hepatocellular carcinoma: What’s new on the horizon?
por: Ocker, Matthias
Publicado: (2018)

Direct, remote and combined ischemic conditioning in liver surgery
por: Stankiewicz, Rafał, et al.
Publicado: (2021)

Current status of surgical management of patients with gastroenteropancreatic neuroendocrine neoplasms
por: Stankiewicz, Rafał, et al.
Publicado: (2022)

Abdominal Ultrasound and Treatment of Hepatocellular Carcinoma
por: Numata, Kazushi
Publicado: (2021)

Recent Advancements for the Treatment of Hepatocellular Carcinoma
por: Nouso, Kazuhiro
Publicado: (2023)

Targeting Cytokines and Their Pathways for the Treatment of Cancer
por: Heimberger, Amy B., et al.
Publicado: (2023)

Exploring new frontiers in neuropsychopharmacology: SSRIs for stroke
por: Sathyanarayana Rao, T. S., et al.
Publicado: (2011)

Exploring new vistas in biomedical journal publishing
por: Abdullah, BJJ, et al.
Publicado: (2006)

New Exploration of Chinese Herbal Medicines in Hepatology
por: Feng, Yibin, et al.
Publicado: (2016)

Exploring New Predictors of Colistin-Associated Nephrotoxicity
por: Kim, Eun Jung, et al.
Publicado: (2018)

Auditing costs of intensive care in cancer patients in India: A new area explored
por: Ray, B.
Publicado: (2013)

Hepatocellular Carcinoma: Updates in Pathogenesis, Detection and Treatment
por: Martínez-Chantar, Maria L., et al.
Publicado: (2020)

Possible Therapies for Hepatocellular Carcinoma—Preparing for the Modern War with the Insidious Enemy
por: Wasilewicz, Michał P.
Publicado: (2023)

Is Sepsis a Cardiac Nemesis? Exploring New Vistas
por: Kapoor, Aditya
Publicado: (2020)

Indian Journal of Orthopaedics: Exploring a new horizon
por: Jain, Anil K.
Publicado: (2011)

Exploring the Complex Link between Autophagy, Regulated Cell Death, and Cell Fate Pathways in Cancer Pathogenesis and Therapy
por: Moosavi, Mohammad Amin, et al.
Publicado: (2023)

Exploring the Cutting Edge of Vision Science: New Developments in Diagnostics and Treatment of Ocular Surface in Dry Eye Disease
por: Sánchez-González, José-María, et al.
Publicado: (2023)

A new era for hepatocellular carcinoma
por: Memeo, Riccardo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ivbn7lcq47lr02cvs0vdhc5rpm